Latest news

Thumbnail image for SMC OKs four new therapies for NHS use in Scotland

SMC OKs four new therapies for NHS use in Scotland

Cost regulators in Scotland have approved NHS funding for four new medicines, expanding treatment options for lung cancer, iron excess, hepatitis C and chronic pain, but Janssen's Darzalex was rejected for multiple myeloma.

17th January 2017

Thumbnail image for AZ expands first-line cancer immunotherapy programme

AZ expands first-line cancer immunotherapy programme

AstraZeneca has expanded a late-stage trial currently assessing a potential new immuno-oncology (IO) therapy combination for the first-line treatment of non-small cell lung cancer (NSCLC), to include extra endpoints for both the combo and monotherapy.

17th January 2017

Thumbnail image for DH invests £35m in vaccines for global epidemics

DH invests £35m in vaccines for global epidemics

The Department of Health is launching a competition later this month offering up to a total of £35 million to help small businesses progress development of new vaccines against infectious diseases.

17th January 2017

Thumbnail image for Sanofi licences ImmuNext autoimmune disease drug

Sanofi licences ImmuNext autoimmune disease drug

Sanofi and ImmuNext have announced an agreement focused on the development of a novel antibody with the potential to treat a range of autoimmune diseases including lupus and multiple sclerosis.

16th January 2017

Thumbnail image for FDA extends review time for Lillys’ RA drug

FDA extends review time for Lillys’ RA drug

US regulators have extended the review period for Eli Lilly and Incyte's baricitinib, a once-daily oral medicine submitted in January last year for the treatment of moderate to severe rheumatoid arthritis.

16th January 2017

Thumbnail image for PharmaTimes Media announces the launch of the prestigious Sales Awards for 2017

PharmaTimes Media announces the launch of the prestigious Sales Awards for 2017

Open to pharma sales representatives and sales managers, candidates in this prominent industry competition are both nominated and judged by healthcare professionals. The PharmaTimes Sales Awards therefore delivers truly meaningful recognition for pharma sales professionals, from the people who matter most: their customers.

13th January 2017

Thumbnail image for BIA knocks new plans for appraising rare disease therapies

BIA knocks new plans for appraising rare disease therapies

The BioIndustry Association is warning that proposals to change to the way medicines and other health technologies are evaluated for NHS use could actually stop the flow of new therapies reaching patients with very rare and complex diseases.

13th January 2017

Thumbnail image for NICE recommends Novartis’ kidney cancer drug

NICE recommends Novartis’ kidney cancer drug

Some patients with kidney cancer should soon be able to get easier access to Novartis' Afinitor on the NHS, after cost regulators backed moving the drug out of the Cancer Drug's Fund and into the routine care pathway

12th January 2017

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download